TSE:CSU

Constellation Software Inc. (CSU.TO)

2,827.94
+68.70 (2.49%)
as of Sep 11, 2026, 8:00:01 pm Market Open.
640 watching
0
Investor Insights
star iconSep 12, 2026, 12:00 am

This summary was created by AI, based on 88 opinions in the last 12 months.

Constellation Software Inc. (CSU) has experienced significant volatility recently, notably due to fears over AI's impact on software companies and the retirement of its long-serving CEO, Mark Leonard. While some analysts express concerns regarding its future growth trajectory and the potential loss of pricing power, many experts believe the company remains fundamentally strong with a robust history of acquisition and capital deployment. The stock is perceived to be undervalued by several analysts, particularly as it trades at lower multiples compared to its historical values. Despite some bearish sentiment, there's a consensus among many that the fears regarding AI displacement may be overstated and could pave the way for the company to leverage AI in enhancing its software offerings. Overall, the prevailing view suggests that CSU presents a buying opportunity for long-term investors, though caution is advised due to technical indicators suggesting potential further downside in the short term.

consensus icon
Consensus
Buy
valuation icon
Valuation
Undervalued
review icon
Similar
Shopify,SHOP
TOP PICK

(A Top Pick April 3/13. Up 113.04%.) Continues to rock. One of the best capital allocators in the market. A superb franchise. Fantastic management team. A stock that you could sleep at nights with. It should certainly be able to continue to outperform the market for the foreseeable future. Generates a lot of cash flow. Can see $350 in a year.

BUY

Stock has more than doubled over the last year. Their whole purpose in life is to basically acquire companies and take the free cash flow, ploughing it back into other companies. Free cash flow yield is 2%, which is a B minus compared to the whole database. Year-over-year earnings growth was up 32% in October. Estimates have risen by 5% over the last 90 days. Earnings are expected to grow by 27% this year, so the PE of 19X against that, gives you a .7 PE to growth ratio. Generally speaking, a PEG of less than 1 is considered attractive.

BUY ON WEAKNESS

(Market Call Minute.) This is a rollup, much the same as Valeant Pharmaceuticals (VRX-T) but Valeant is much cheaper. This stock closed at $223 and his model price is $181, 18% lower. Wait for a pullback.

DON'T BUY

Quite phenomenal just how well this company has been run, and how well their acquisitions have improved their earnings. In making acquisitions, the challenge over a period of 5 years is finding big competitors that want to be acquired. These are the challenges this company is going to face over the next couple of years. This looks fully valued to him.

BUY

Specialty software company that buys niche companies in niche businesses.

TOP PICK

15 times cash earnings growing at at least 35%. Best performing large cap stock in Canada over the last 5 years. Made an acquisition a week ago that will contribute 15% growth on their current base of earnings.

HOLD

Been a tremendous story. Likes the management team. Growth through acquisition. Multiple is high but they have done a good job. Don’t sell here.

BUY

Fantastic company. Run very well making acquisitions of technology companies and rolling them in. Going to be a good stock for a long time. He has been waiting for an entry point for a long time. As they get bigger, they can make more and bigger acquisitions, accelerating their growth plans. Thinks they have a pretty decent runway for the next little while.

DON'T BUY

Hit a new five-year high. Volume was 72,000 that is normally 33,000. Trending higher. He would be careful as it is a thin trader. There are some money managers that favour this stock. Any bad news on earnings and there will be a rush for the exits and he wouldn’t want to be in the way. Very expensive and he feels there are better places to be.

TOP PICK

Look at the chart. Another good year for the chart, 10 fold rise since ’09. 39% return on equity. RBC raised their target price.

HOLD

Probably the smartest software guys in Canada, but smart from an acquisition standpoint. They are not focused on the growth side. Their whole thing is growth by acquisition. When a stock gets to be 14 or 15 times EBITDA he really looks for the Exit sign. He did on this one but was way too soon. Thinks it will always have a premier cachet to it. If it pulled back to $140, he would be looking to buy it.

PARTIAL BUY

Their business model seems to be fairly firmly entrenched. They don’t really vary from the typical type of software companies that they are involved in. Smart management. He has been getting numbers above $171 stocks but it doesn’t seem to matter. If you don’t own, you could do a little.

BUY ON WEAKNESS

A good, long-term stock and it is getting better with time. They acquire more software companies allowing them to make even bigger acquisitions. They take all of that and then funnel the free cash flow down. Has been waiting for a good entry point. Not overly expensive.

TOP PICK

Best capital allocator management in Canada. Thinks the stock will go to $250 in the next 12 months. Only trading at 12.5X earnings.

HOLD

His model prices $148.96, a -4% or -5%. Would love to see some sort pullback.

Showing 406 to 420 of 448 entries